-
Je něco špatně v tomto záznamu ?
Childhood cancer epidemiology in the Czech Republic (1994-2016)
D. Krejci, M. Zapletalova, I. Svobodova, V. Bajciova, P. Mudry, V. Smelhaus, J. Sterba, J. Stary, R. Capocaccia, L. Dusek
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
ProQuest Central
od 2009-07-01 do Před 2 měsíci
Nursing & Allied Health Database (ProQuest)
od 2009-07-01 do Před 2 měsíci
Health & Medicine (ProQuest)
od 2009-07-01 do Před 2 měsíci
Health Management Database (ProQuest)
od 2009-07-01 do Před 2 měsíci
Public Health Database (ProQuest)
od 2009-07-01 do Před 2 měsíci
- MeSH
- dítě MeSH
- incidence MeSH
- kojenec MeSH
- lidé MeSH
- míra přežití MeSH
- mladiství MeSH
- nádory epidemiologie MeSH
- novorozenec MeSH
- předškolní dítě MeSH
- Check Tag
- dítě MeSH
- kojenec MeSH
- lidé MeSH
- mladiství MeSH
- mužské pohlaví MeSH
- novorozenec MeSH
- předškolní dítě MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Geografické názvy
- Česká republika MeSH
BACKGROUND: The knowledge of cancer burden in the population, its time trends and the possibility of international comparison is an important starting point for cancer control programmes. Our study aimed to evaluate trends in childhood cancer epidemiology of patients aged 0-14 years in the period 1994-2016 in the Czech Republic. METHODS: Data on childhood cancers have been obtained from the Czech National Cancer Registry. These data were validated using the clinical database of childhood cancer patients and combined with data from death certificates. Incidence and mortality trends were assessed by the joinpoint regression method. The life tables method was used to calculate the overall age-standardised five-year survival. RESULTS: The incidence trend was stable; the age-standardised (world) cancer incidence - ASR (W) - was 173.7 per 1 million children in the period 1994-2016. However, there was apparent significant decrease in mortality: ASR (W) dropped from 58.1 per 1 million children in 1994 to 21.4 per 1 million children in 2016. The overall five-year survival increased over time by 10 %. Statistically significant improvements in survival were observed in patients with lymphoid leukaemia, astrocytomas, neuroblastomas, osteosarcomas and rhabdomyosarcomas. CONCLUSION: Such a relevant increase in survival rates, and therefore also a decrease in mortality rates in the Czech Republic, is most likely due to improvements in diagnostic and treatment methods since the 1990s, which were facilitated by the concentration of childhood cancer patients in children's cancer centres.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21019699
- 003
- CZ-PrNML
- 005
- 20210830101301.0
- 007
- ta
- 008
- 210728s2020 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.canep.2020.101848 $2 doi
- 035 __
- $a (PubMed)33223489
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Krejci, Denisa $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Kamenice 126/3, 62500, Brno, Czech Republic; Institute of Health Information and Statistics of the Czech Republic, Palackeho namesti 4, 12801, Prague 2, Czech Republic. Electronic address: krejcid@iba.muni.cz
- 245 10
- $a Childhood cancer epidemiology in the Czech Republic (1994-2016) / $c D. Krejci, M. Zapletalova, I. Svobodova, V. Bajciova, P. Mudry, V. Smelhaus, J. Sterba, J. Stary, R. Capocaccia, L. Dusek
- 520 9_
- $a BACKGROUND: The knowledge of cancer burden in the population, its time trends and the possibility of international comparison is an important starting point for cancer control programmes. Our study aimed to evaluate trends in childhood cancer epidemiology of patients aged 0-14 years in the period 1994-2016 in the Czech Republic. METHODS: Data on childhood cancers have been obtained from the Czech National Cancer Registry. These data were validated using the clinical database of childhood cancer patients and combined with data from death certificates. Incidence and mortality trends were assessed by the joinpoint regression method. The life tables method was used to calculate the overall age-standardised five-year survival. RESULTS: The incidence trend was stable; the age-standardised (world) cancer incidence - ASR (W) - was 173.7 per 1 million children in the period 1994-2016. However, there was apparent significant decrease in mortality: ASR (W) dropped from 58.1 per 1 million children in 1994 to 21.4 per 1 million children in 2016. The overall five-year survival increased over time by 10 %. Statistically significant improvements in survival were observed in patients with lymphoid leukaemia, astrocytomas, neuroblastomas, osteosarcomas and rhabdomyosarcomas. CONCLUSION: Such a relevant increase in survival rates, and therefore also a decrease in mortality rates in the Czech Republic, is most likely due to improvements in diagnostic and treatment methods since the 1990s, which were facilitated by the concentration of childhood cancer patients in children's cancer centres.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a incidence $7 D015994
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a novorozenec $7 D007231
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a nádory $x epidemiologie $7 D009369
- 650 _2
- $a míra přežití $7 D015996
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Zapletalova, Michaela $u Institute of Health Information and Statistics of the Czech Republic, Palackeho namesti 4, 12801, Prague 2, Czech Republic
- 700 1_
- $a Svobodova, Ivana $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Kamenice 126/3, 62500, Brno, Czech Republic; Institute of Health Information and Statistics of the Czech Republic, Palackeho namesti 4, 12801, Prague 2, Czech Republic
- 700 1_
- $a Bajciova, Viera $u Department of Paediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Cernopolni 9, 62500, Brno, Czech Republic
- 700 1_
- $a Mudry, Peter $u Department of Paediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Cernopolni 9, 62500, Brno, Czech Republic
- 700 1_
- $a Smelhaus, Vratislav $u Department of Paediatric Haematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital in Motol, V Uvalu 84, 15006, Prague 5, Czech Republic
- 700 1_
- $a Sterba, Jaroslav $u Department of Paediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Cernopolni 9, 62500, Brno, Czech Republic
- 700 1_
- $a Stary, Jan $u Department of Paediatric Haematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital in Motol, V Uvalu 84, 15006, Prague 5, Czech Republic
- 700 1_
- $a Capocaccia, Riccardo $u Cancer Epidemiology Unit, National Center of Epidemiology, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy
- 700 1_
- $a Dusek, Ladislav $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Kamenice 126/3, 62500, Brno, Czech Republic; Institute of Health Information and Statistics of the Czech Republic, Palackeho namesti 4, 12801, Prague 2, Czech Republic
- 773 0_
- $w MED00166636 $t Cancer epidemiology $x 1877-783X $g Roč. 69, č. - (2020), s. 101848
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33223489 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830101301 $b ABA008
- 999 __
- $a ok $b bmc $g 1690498 $s 1140145
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 69 $c - $d 101848 $e 20201119 $i 1877-783X $m Cancer epidemiology $n Cancer Epidemiol $x MED00166636
- LZP __
- $a Pubmed-20210728
